KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Non-Current Assets: 2010-2015

Historic Non-Current Assets for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to $54.5 million.

  • Biocryst Pharmaceuticals' Non-Current Assets rose 2648.81% to $54.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was $54.5 million, marking a year-over-year increase of 2648.81%. This contributed to the annual value of $47.5 million for FY2014, which is 604.68% up from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Non-Current Assets of $54.5 million as of Q3 2015, which was up 26.36% from $43.1 million recorded in Q2 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Non-Current Assets registered a high of $54.5 million during Q3 2015, and its lowest value of $2.0 million during Q3 2014.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Non-Current Assets value was $7.7 million (recorded in 2014), while the average stood at $21.6 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first slumped by 79.51% in 2013, then surged by 2,648.81% in 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Non-Current Assets (Quarterly) stood at $29.4 million in 2011, then slumped by 47.32% to $15.5 million in 2012, then tumbled by 56.37% to $6.7 million in 2013, then surged by 604.68% to $47.5 million in 2014, then spiked by 2,648.81% to $54.5 million in 2015.
  • Its Non-Current Assets was $54.5 million in Q3 2015, compared to $43.1 million in Q2 2015 and $48.5 million in Q1 2015.